The high TXLNA expression group had favourable OS in PAAD patients with no-smoking history (p=0.0101; HR: 0.366; 95% CI: 0.1701–0.7872; Figure 3(e)), but not in PAAD patients with smoking history (p=0.3236; HR: 0.6551; 95% CI: 0.2828–1.5174; Figure 3(f)). This evidence concerns the gene TXLNA and pancreatic adenocarcinoma.